china's plans to import indian drugs fail to enthuse indian pharmaceutical firms
.
.turn on desktop notifications for breaking stories about interest?
.
.
.
.
it also provides 85 per cent accurate prediction results than current methods. . eptinezumab is in phase iii trials. its maker plans to submit an application with the fda later this year. it is for chronic migraine prevention.
it also provides 85 per cent accurate prediction results than current methods. .
$17
OFF DEAL
OFF DEAL
GET DEAL
218 Used Today
50%
OFF DEAL
OFF DEAL
GET DEAL
181 Used Today
$20
OFF DEAL
OFF DEAL